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Abstract
Minimizing the number of patients exposed to potentially harmful drugs in early onco-
logical trials is a major concern during planning. Adaptive designs account for the inherent
uncertainty about the true effect size by determining the final sample size within an ongoing
trial after an interim look at the data. We formulate the problem of finding adaptive designs
which minimize expected sample size under the null hypothesis for single-arm trials with
binary outcome as an integer linear program. This representation can be used to identify
optimal adaptive designs which improve previous designs in two ways: Firstly, designs can
be found exhibiting lower expected sample size under the null hypothesis than those pro-
vided by previous algorithms. Secondly, we explain how integer programming techniques
can be exploited to remove pathologies of the optimal and previous solutions arising from
the discrete nature of the underlying statistics. The resulting designs are both efficient in
terms of expected sample size under the null hypothesis and well interpretable.
1 Introduction
Early phase II studies in clinical oncology are conducted after investigation of safety and dosage of
a new anti-tumor agent in preceding phase I studies. The objective of such early phase II trials
is to identify substances that show promising anti-tumor activity warranting further research
in larger phase II or confirmatory phase III studies. Usually, early phase II trials in clinical
oncology are designed as single-arm studies with a binary endpoint indicating whether patients
had substantial tumor remission or, at least, no progression during a defined follow-up period.
Let ρ be the probability of observing a favorable outcome (response) of the binary endpoint. The
main interest lies in testing the null hypothesis H0 : ρ ≤ ρ0 for some pre-specified value ρ0 chosen
as the maximal value still considered clinically uninteresting. Due to the early stage of clinical
research at which this type of study is conducted, there is usually a high degree of uncertainty
about the magnitude of ρ. In order to compensate for this uncertainty during planning, group
sequential designs (Jennison and Turnbull, 1999) can be employed which allow early stopping for
futility or efficacy at pre-defined stages. The large logistical effort of conducting interim analyses
and the long follow-up times for oncological endpoints render multiple stages or strictly sequential
testing impractical. Instead, designs involving a single interim analysis after observing a pre-
specified number of patients are viable compromises between the requirements of clinical practice
and the desire for the option of early stopping for either futility or efficacy. In his seminal paper,
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Simon (1989) derived two types of two-stage group sequential designs which either minimize the
expected sample size under the null hypothesis (Simon’s optimal designs) or the maximal sample
size (Simon’s minimax designs). Other optimality criteria have been proposed in the literature.
For example, Shuster (2002) aimed at optimizing the maximal expected sample size over the
complete range of success probabilities. In the following, we focus on the optimality criterion of
Simon’s optimal designs. This is due to its wide acceptance among practitioners and its intuitive
appeal: When testing potentially harmful substances in vivo one would like to minimize the
number of patients exposed to non-active or even harmful drugs. Should, on the other hand, the
drug under investigation be beneficial, administering it to a larger number of patients within the
study is unproblematic. Therefore, minimizing expected sample size under the null hypothesis
better meets the ethical requirements than, say, minimizing expected sample size under a pre-
specified alternative value ρ1 > ρ0. While two-stage designs allow early stopping in case of
lower or higher treatment effect than assumed in the planning stage, they require that initially
defined sample sizes and decision rules are to be followed strictly in order to assure control of
the type one error rate. During the last years, the development of more flexible methods for
reacting to the observed interim outcome of a trial have lead to an increasing research effort
concerning so-called adaptive designs (Bauer et al., 2015). This class of designs allows not only
to stop early for futility or efficacy but also to adjust the sample size of the second stage based
on the observed interim outcome as long as the conditional error of the initially planned design
is preserved. Transferring the conditional error function principle (Mu¨ller and Scha¨fer, 2004)
to discrete data, Englert and Kieser (2012b,a) derived flexible designs for single-arm studies
with binary endpoints. Furthermore, formulating the decision rules in terms of the discrete
conditional error function results in counterparts of Simon’s designs that are flexible and at the
same time as least as efficient if the pre-defined sample size is not changed. The same theoretical
framework can be used to find sample size adaptation rules that are optimal with respect to, e.g.,
the expected sample size under the null hypothesis thus extending Simon’s designs in a natural
way. Previous approaches to the problem of finding optimal adaptive designs in the sense of
Simon (1989) needed to impose technical constraints in order to render the optimization feasible.
Englert and Kieser (2013) imposed the additional constraint that the conditional error function
of the design should be non-decreasing in the number of observed positive outcomes after stage
one (EK designs). While it might be intuitive to ‘shift’ type one error to more promising stage-
one outcomes, this was primarily a constraint for technical convenience as it also guarantees
consistent regions for stopping for futility (conditional error of 0) or efficacy (conditional error
of 1). Yet, in some situations, the conditional error constraint is not sufficient to prevent the
sample size function of the designs from being shaped oddly. For example, the optimal design
for ρ0 = 0.5, a fixed alternative value of 0.7, and α = 0.05, β = 0.1 in Englert and Kieser (2013)
requires 47 subjects for stage two upon observing 13 responses out of 20 subjects in stage one,
44 for 14 responses but 47 again for 15 responses (Table 1 in Englert and Kieser (2013)). This
non-smooth sample size function resulting from the discreteness of the underlying distribution is
unintuitive and might impede adoption of these designs in practice.
The goal of this paper is two-fold. Firstly, we demonstrate that the problem can be solved
in feasible time without any additional technical constraints using binary linear programming,
cf. Garfinkel and Nemhauser (1972); Conforti et al. (2014). Subsequently, we investigate how
restrictive the monotone conditional error constraint of Englert and Kieser is in practice and
suggest a novel approach to obtaining ‘nice’ solutions which prevent the potential pathologies of
sample size function with negligible increase of the expected sample size under the null hypothesis.
The remainder of this paper is organized as follows. In Section 2, we introduce the notation
used throughout the paper and describe the optimization problem for Simon’s optimality crite-
rion in an adaptive two-stage setting. Section 3 explains how the problem can be formulated
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as a binary linear program with minimal constraints, and Section 4 explains the link to previ-
ous algorithms and explores the possibility of improving the quality of the solutions obtained
with respect to various aspects. A numerical comparison for a range of commonly encountered
parameter configurations is given in Section 5. The discussion in Section 6 highlights the main
differences of our approach to previous work and gives a prospect of possible extensions.
2 Notation
Throughout this paper, we consider two-stage single-arm clinical trial designs with binary end-
point. A pre-defined number of patients is enrolled during the first stage. Based on the number of
observed responses and a pre-defined sample size function, it is then decided how many patients
are included in the second stage. It is possible to stop early either for futility or for efficacy after
the first stage.
Let n1 be the number of patients enrolled in stage one, X1 the number of responses observed
in stage one, X2 the number of responses observed in stage two and X = X1 + X2 the overall
observed number of such events. The interest lies in testing H0 : ρ ≤ ρ0 for a pre-specified type
one error rate α and a type two error rate β at an alternative parameter value ρ1 > ρ0. Any two-
stage design addressing this test problem can be described as a tuple
(
n, c
)
of the total sample
size function n : {0, 1, . . . , n1} → {n1, n1 + 1, . . . , nmax} and the overall critical value function
c : {0, 1, . . . , n1} → {0, 1, . . . , nmax}∪ {−∞,∞}, where n1 is the number of patients pre-planned
for the first stage and nmax is the maximal total sample size. For any observed number of
responses at interim x1, the total sample size function n(x1) determines the number of patients
enrolled in both stages and therefore the number needed for the second stage. After completing
stage-two, the null hypothesis is rejected if and only if X > c(x1). Besides nmax ≥ n1, the
functions n(·) and c(·) must fulfill the following consistency constraints for all x1 ∈ {0, . . . , n1}
c(x1) ∈ {−∞,∞} ⇔ n(x1) = n1 (1)
n(x1) > n1 ⇒ n(x1) > c(x1) ≥ x1,
which ensure that the final test decision is not yet fixed when continuing to the second stage.
3 Optimal two-stage design
Finding the optimal adaptive two-stage design for given type one and type two error rates
α, β using Simon’s classical optimality criterion of minimal expected sample size under the null
hypothesis can be formulated as the following optimization problem
minimize
n1, n(·), c(·)
Eρ0
[
n(X1)
]
subject to Pρ
[
X > c(X1)
] ≤ α ∀ ρ ≤ ρ0
Pρ1
[
X > c(X1)
] ≥ 1− β.
Note that all quantities involved are discrete and therefore specialized techniques are needed to
solve the problem, which is not linear in the original variables c(x1), n(x1), x1 = 0, . . . , n1. By
reformulation as assignment problem using auxiliary variables it can, however, be stated as a
binary linear program. This class of problems can be solved efficiently with existing software.
Firstly, we simplify he problem by considering the optimization problem only for a particular
value of n1. The optimization over n1 can then be performed by solving the conditional problem
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to optimality for every n1 = 1, 2, . . . until n1 > Eρ0
[
n(X1)
]
. Let to this end for fixed n1(
yx1,n2,c
)
,
x1 = 0 . . . n1, n2 = 0 . . . nmax − n1, c = −∞, 0, . . . , nmax − 1,∞ be the three-dimensional binary
assignment array with yx1,n2,c = 1 if and only if n(x1)− n1 = n2, and c(x1) = c. The fact that
n(·) and c(·) must be valid functions of x1 is easily represented by constraints of the form∑
n2,c
yx1,n2,c = 1 ∀x1 = 0 . . . n1.
The consistency constraints on n(·) and c(·) in equations (1) can be implemented as follows
yx1,n2,c = 0 if c(x1) ∈ {−∞,∞} ∧ n2 ∈ {n1 + 1, . . . , nmax}
yx1,n1,c = 0 if c 6∈ {−∞,∞}
yx1,n2,c = 0 if n2 > 0 ∧
(
c < x1 ∨ n2 + n1 ≤ c
)
.
Additionally, let
(
cex1,n2,c
)
be the corresponding three-dimensional array holding the respective
conditional errors ce(x1), i.e.,
cex1,n2,c := Pρ0
[
X1 +X2 > c |X1 = x1
]
= Pρ0
[
X2 > c− x1
]
, (2)
and
(
cpx1,n2,c
)
the three-dimensional array holding the conditional power cp(x1) for each config-
uration, i.e.,
cpx1,n2,c := Pρ1
[
X1 +X2 > c |X1 = x1
]
= Pρ1
[
X2 > c− x1
]
. (3)
Further, let
(
nx1,n2,c
)
be the three-dimensional array of corresponding sample sizes, i.e.,
nx1,n2,c := n2 + n1. (4)
The objective criterion can then be expressed as
minimize(
yx1,n2,c
) ∑
x1,n2,c
Pρ0
[
X1 = x1
] · nx1,n2,c · yx1,n2,c (5)
which is linear in the binary assignment variables yx1,n2,c. An overall power of 1 − β at ρ1 is
guaranteed by the linear constraint∑
x1,n2,c
Pρ1
[
X1 = x1
] · cpx1,n2,c · yx1,n2,c ≥ 1− β. (6)
Controlling the overall maximal type one error rate at α is more complicated. Intuitively, the
type one error rate should be largest at the boundary of the null hypothesis in which case the
linear constraint ∑
x1,n2,c
Pρ0
[
X1 = x1
] · cex1,n2,c · yx1,n2,c ≤ α (7)
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Table 1: Sample size function n(·) and critical value function c(·) of the unconstrained (‘optimal’),
the monotone conditional error (‘EK’), and the unimodal sample size function (‘nice’) adaptive
designs for the example given in Section 3.
Design Type x1: 0 1 2 3 4 5 6 7 8 9 10
Optimal n(x1): 10 10 17 38 40 36 39 10 27 10 10
c(x1): ∞ ∞ 5 11 12 11 11 -∞ 10 - ∞ - ∞
EK n(x1): 10 10 17 38 40 36 39 22 10 10 10
c(x1): ∞ ∞ 5 11 12 11 11 7 -∞ -∞ -∞
Nice n(x1): 10 10 17 38 40 37 35 19 10 10 10
c(x1): ∞ ∞ 5 11 12 11 11 7 -∞ -∞ -∞
would be sufficient to maintain type one error rate control. Yet, we were unable to prove that
this constraint is sufficient to achieve strict type one error rate control on H0. We therefore
resort to solving the problem only controlling the type one error rate at the boundary of the null
hypothesis and numerically verify strict type one error rate control for the solutions obtained.
For all situations considered here the resulting designs maintained strict type one error rate
control.
As an example, let n1 = 10, nmax = 40, α = 0.05, β = 0.2, ρ0 = 0.2 and ρ1 = 0.4. Table 1
and Figure 1 show the optimal adaptive design (‘optimal’) besides various modifications using
additional constraints which are discussed in Section 4. The optimal design has an expected
sample size of 21.241. Although it violates monotonicity of ce(·) it still controls the type one error
rate at 0.05, which we checked numerically. Therefore, the example shows that a monotone
conditional error function is not a necessary condition for strict type one error rate control. Also
note that the stopping regions of the optimal design are not contiguous. In fact, the design stops
for futility when observing 15 out of 15 responses in stage one. Although optimal in the sense of
the specified criterion, such a behavior is not acceptable in practice and needs to be addressed.
In Section 4 we first illustrate how the solutions of Englert and Kieser can be re-produced
within the framework presented here and then explore alternative options for regularization of
the optimization problem.
4 Regularizing the solution with additional constraints
4.1 Monotone conditional error function
The solutions obtained by the branch-and-bound algorithm suggested by Englert and Kieser
(2013) can be reproduced by adding constraints to the optimization problem that enforce a
monotone conditional error function. As a consequence, it is immediately clear that any solution
obtained without these constraints (‘optimal’ designs) will be at least as good as the one obtained
by the EK algorithm in terms of the expected sample size under the null hypothesis. Monotonicity
of the conditional error function can be enforced by n1 additional constraints of the form∑
n2,c
cex1,n2,c
(
yx1,n2,c − yx1−1,n2,c
) ≥ 0
for x1 ∈ {1, . . . , n1}. As the example in Table 1 shows, however, the monotone conditional error
function constraints on their own do not suffice to ensure ‘nice’ solutions with sufficient practical
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Figure 1: Sample size function n(·), critical value function c(·), conditional error function ce(·),
and conditional power function cp(·) of the discussed adaptive designs for the example given in
Section 3.
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appeal. While the EK design achieves contiguous stopping regions, which are implied by a
monotone conditional error function, it does not guarantee a smooth sample size function. The
expected sample size under the null hypothesis is only slightly larger than the optimal solution’s
(21.250 vs. 20.241).
4.2 Contiguous stopping regions
In order to obtain stopping regions which are connected to their respective boundary (in case
of stopping for futility to x1 = 0 and in case of stopping for efficacy to x1 = n1), one needs to
enforce that for any fixed x∗1 ∈ {0, . . . , n1} the following property holds: c(x∗1) =∞⇒ c(x1) =∞
for all x1 < x
∗
1 and vice versa c(x
∗
1) = −∞⇒ c(x1) = −∞ for all x1 > x∗1. This set of conditional
constraints can be formalized via 2n1 new binary variables y
fut
x1 ∈ {0, 1} for x1 ∈ {1, . . . , n1}
and yeffx1 ∈ {0, 1} for x1 ∈ {0, . . . , n1 − 1}. Let for x1 ∈ {1, . . . , n1}
yx1,n1,∞ − yfutx1 = 0.
Then yfutx1 = 1 if and only if c(x1) =∞ (stopping for futility). Adding a second constraint
yx1−1,n1,∞ − yfutx1 ≥ 0
enforces that c(x1−1) =∞ whenever yfutx1 = 1. Therefore, by transitivity all stage-one outcomes
smaller than x1 must also lead to stopping for futility. Similarly, constraints for y
eff
x1 , x1 ∈{0, . . . , n1 − 1} can be constructed to ensure a contiguous stopping for efficacy region connected
to x1 = n1
yx1,n1,−∞ − yeffx1 = 0
yx1+1,n1,−∞ − yeffx1 ≥ 0.
While contiguous stopping regions are obviously implied by a monotonously increasing condi-
tional error function, the opposite is not true an therefore any design using only the contiguous
stopping regions constraints instead of enforcing a monotone ce(·) has more flexibility between
the stopping regions. In some cases, this additional flexibility might lead to a better performance
in terms of minimal expected sample size under the null hypothesis.
4.3 Unimodal sample size function
Motivated by the characteristics of the optimal solutions and the EK designs, we propose to
resolve the issue of potentially unintuitive sample size functions by enforcing unimodality of the
sample size function, which can be obtained by restricting the number of sign changes from
positive to negative of the first order differences of n(·) to one. This implies that at most one
strict local maximum of the sample size function exists. To this end, n1 + 1 additional binary
auxiliary variables y∧x1 ∈ {0, 1}, x1 ∈ {0, . . . , n1} and constraint sets∑
n2,c
nx′1,n2,c · yx′1,n2,c − n(x1−1),n2,c · y(x1−1),n2,c − 2 · nmax · y∧i ≥ −2 · nmax, (8)
x′1 ∈ {1, . . . , x1} are needed. Whenever y∧x1 = 1 these constraints enforce non-negative increments
of n2(x
′
1) for all x
′
1 < x1. Similarly, non-positive increments for values larger than x1 can be
guaranteed by∑
n2,c
nx′1,n2,c · yx′1,n2,c − n(x′1−1),n2,c · y(x′1−1),n2,c + 2 · nmax · y∧x1 ≤ 2 · nmax (9)
7
for x′1 ∈ {x1, . . . , n1}. Finally, one must ensure that at least one of the above designed constraint
sets is active in the solution. This can be achieved by
n1∑
x1=0
y∧x1 ≥ 1. (10)
Jointly, the constraints for contiguous stopping regions and a unimodal sample size function result
in designs which exhibit a ‘smooth’ (unimodal) sample size function in all cases and guarantee
that the stopping for efficacy and futility regions are contiguous and connected to their respective
boundaries. For the example given above the inflation of the expected sample size as compared
to the optimal design is still negligible (21.252 vs. 21.241).
5 Results
We compared the expected sample size under the respective null hypotheses for four different
sets of constraints over a range of parameter values for ρ0 = 0.1, 0.2, . . . , 0.7 and ρ1 = ρ0 + 0.2.
In all cases, we set α = 0.05 and β = 0.2. The search space for n1 and nmax was chosen with
reference to Simon’s original designs (Simon, 1989). We allowed nmax to be 10% larger than
the combined stage-one and stage-two sample size of the corresponding optimal design identified
by Simon. The search range for n1 was chosen from 5 up to nmax − 5. Table 2 shows the
results. In all cases we numerically verified strict type one error rate control of the solutions.
Note that the small deviations from the figures reported in Englert and Kieser (2013) originate
from the fact that we did not need to restrict possible assignments by specifying a minimal
or maximal conditional power in order to render the optimization feasible. All computations
were conducted in the programming language Julia (Bezanson et al., 2014) using its interface
(Lubin and Dunning, 2015) to the commercial Gurobi solver (Gurobi Optimization, Inc., 2015).
Graphics were produced using R (R Core Team, 2015) and the ggplot2 package (Wickham, 2009).
The reference for our comparison is the optimal adaptive design without any additional
constraints. This design allows for maximal flexibility and must therefore exhibit the smallest
expected sample size under the null hypothesis. Furthermore, we included designs equivalent
to the ones obtained by Englert and Kieser by adding the monotone conditional error function
constraint and ‘nice’ designs which use the constraint-sets for contiguous stopping and unimodal
sample size function. The large search space with relatively high nmax as compared to the
example from Section 3 results in the EK design mostly coinciding with the optimal and the
‘nice’ design. This indicates that the monotone conditional error function constraint is most
restrictive when nmax is relatively small, as it is the case in the example from Section 3. In
practice, however, nmax need not always be chosen liberally due to operational constraints. It
is therefore important that the unimodal sample size constraint guarantees intuitive sample size
functions in any situation. For the parameter constellations considered here, both for ρ0 = 0.3
and ρ0 = 0.5, the EK and ‘nice’ designs differ slightly despite the relatively large nmax because
the EK design’s sample size function is not unimodal, cf. Table 2.
Overall, the differences in expected sample size between the optimal, EK, and nice designs
are small for the situation considered here. This indicates that the conditional error function
approach of Englert and Kieser is not unnecessarily restrictive. However, the small differences
to the nice designs demonstrate that the occasional issues with unintuitive sample size function
can be resolved at minimal additional costs in terms of expected sample size under the null
hypothesis.
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Table 2: Results for four different adaptive and Simon’s designs using various combinations of
the constraint sets discussed in Section 4.‘ · · · ’ indicate the same result as to the left; ∗: figures
were taken from the original publication.
Parameters Eρ0
[
n(X1)
]
ρ0 ρ1 Optimal EK Nice Simon’s*
0.1 0.3 14.65107 14.72498 · · · 15.0
0.2 0.4 19.78640 · · · · · · 20.6
0.3 0.5 23.02199 · · · 23.02448 23.6
0.4 0.6 24.08002 24.08640 · · · 24.5
0.5 0.7 22.94827 · · · 22.95923 23.5
0.6 0.8 19.71893 · · · · · · 20.5
0.7 0.9 14.82367 · · · · · · 14.8
6 Discussion
We presented a framework for extending the classical optimality criterion of Simon (1989) to
arbitrary adaptive two-stage designs improving previous work in two ways: Firstly, we demon-
strated how the problem can be formulated as a binary linear program which makes it amenable
to solution by standardized and highly specialized software. In this way, for the first time, we
were able to solve the problem to optimality without any additional technical constraints. Com-
paring the newly found optimal designs with the ones obtained previously by Englert and Kieser
(2013), we conclude that the performance improvements in terms of expected sample size under
the null hypothesis are almost negligible. Consequently, we conclude that the monotone condi-
tional error constraint is not unnecessarily restrictive. Secondly, we utilized the binary linear
program formulation to enforce certain desirable features of solutions obtained, which resolve
problems arising due to the discreteness of the underlying statistics while preserving most of
the advantages in terms of Simon’s optimality criterion. When comparing the optimal solutions
without any additional constraints to the ones obtained by adding ‘niceness’ constraints such
as unimodality of the sample size function or contiguous stopping regions. For many parameter
settings the solutions coincide with the ones found by the algorithm of Englert and Kieser and
where they differ due to a non-unimodal sample size function of the latter the performance loss
in terms of expected sample size under the null hypothesis is extremely small. Additionally,
the fact that we formulated the problem in terms of a binary linear program allowed us to use
commercial grade software for its solution. Thus, the solutions can be obtained very quickly
which is a great improvement over naive implementations of the branch-and-bound algorithm.
Note that the binary linear programming framework presented in this paper also allows the
addition of further constraints which can be used to tailor the solution’s properties towards
custom needs or preferences. For example, one might chose to require a conditional power of at
least 1 − β upon continuing to the second stage which would render sample size re-calculation
based on conditional power unnecessary.
We considered expected sample size under the null hypothesis as optimality criterion. How-
ever, we would like to mention that it is straightforward to instead minimize the expected sample
size under, e.g., some Bayesian prior distribution over ρ, which could then be seen as an extension
of the ideas of Dong et al. (2012).
Simon (1989) also considered so-called ‘minimax designs’ which minimize the maximal total
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sample size of the design. Unfortunately, while it is theoretically possible to express minimax
objective functions in terms of a binary linear program (Bisshop, 2015), this is not feasible in
practice as the number of additional constraints required is extremely large. Although adaptive
versions of Simon’s minimax designs are thereby practically out of reach of the generic binary
linear programming approach, it is still possible to modify the objective function to favor designs
with smaller maximal sample sizes. This can be achieved by minimizing Eρ0
[
n(X1)
γ
]
for γ > 1
orEρ0
[
exp
(
n(X1)
) ]
instead ofEρ0
[
n(X1)
]
. Each of these objective functions is easily obtained
by piecewise modifications of the respective coefficients. Alternatively, the parameter nmax might
be used more restrictively to obtain a solution with acceptable maximal sample size.
Although all methods presented in this paper are developed for rate comparisons of a sin-
gle binomial random variable, an extension to more complex hypothesis tests based on, e.g.,
multinomial variables can be derived along the same lines.
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